What’s Trending in Hard Capsules for Pharmaceutical Applications?

Why are solid oral dosage formats the most popular formats? Because these delivery systems are the most patient-friendly. They are easy to swallow, easy to transport and do not involve…

Ensuring Business Continuity in Uncertain Times: Understanding Five Risk Categories that Can Lead to Better Mitigation Strategies

In a time where businesses are being forced to come up with contingency plans for pandemics, one industry that is particularly vulnerable is the pharmaceuticals sector. The supply chains that…

Nanomilling ― For Improved Solubility and Bioavailability

A crucial feature of drug development is bioavailability, defined as “the ability of a drug to be absorbed and used by the body.” For a drug to be bioavailable, it…

Small Molecule Orphan Drugs: Balancing Financial Incentives And Complex Challenges

Author: Kevin Kane, Global SME, Thermo Fisher Scientific Abstract:The orphan drug industry focuses on developing life-changing and potentially life-saving treatments for patients living with rare diseases. Previously, the needs of…
CapsCanada

Interchangeability Between Hard Gelatin and Hard Hypromellose Capsules Without Gelling Agent

PurposeHard gelatin capsules have long been used in a substantial proportion of oral dosage forms. However, they have some shortcomings. Concerns include the potential to become cross-linked, resulting in problems…
Altasciences

Applications of Liquid-Filled Capsules for Challenging APIs in Pharmaceutical Manufacturing

Liquid-filled capsules offer significant benefits for active pharmaceutical ingredients (APIs) presenting formulation or manufacturing challenges. Their use is beneficial throughout the different phases of drug development, from preclinical to commercialization.…

Monoclonal Antibody Manufacturing for BioPharma: To Build or Outsource?

As the global biologics market continues to grow, securing speed with scale has never been a greater priority. Here we demonstrate important factors to consider in making optimal outsourcing decisions…

Setting The Right Goals: Go Digital, Not Paperless

Digital transformation initiatives can often times result in false starts and inefficiencies by overemphasizing “paperless” environments. Such endeavors focus on identifying and converting paper-based forms and procedures to electronic means,…

N-nitrosamines in Drug Products: Overview, Challenges and Lessons Learned from an API Manufacturer’s Perspective

By Karina Boszko, Head of API Regulatory Affairs and Customer Technical Support Department, Polpharma API Nitrosamines—how has it all started?In July 2018, the pharmaceutical industry was surprised by the unexpected…